Data Management

End-to-end data management

Avance Clinical’s data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.

Technology

The company has focussed on state-of-the-art technology and systems across all functional areas to provide clients with the most effective processes. Medidata, Oracle, and Medrio are just some of the technology partners.

Avance Clinical offers globally accepted data from an established clinical trial ecosystem, that includes world-class PIs and Sites that are able to rapidly access specialized patient groups.

Data Management Services

Avance Clinical data is accepted by all major regulatory authorities around the globe including the FDA.

The Avance Clinical Data Management Team provides accurate and precise end-to-end data management services.

World-class reputation

Our clinical data management team has gained a world-class reputation for accuracy, precision, and quality of their biostatistics and pharmacokinetic (PK) analysis.

In-house end-to-end clinical data management

Our highly experienced staff provides seamless in-house end-to-end clinical data management services using streamlined capture, analysis, and reporting pathways to deliver your team quality data sets.

e-CRF development and validation using Medrio
CDASH conforming CRF design
e-PRO
Edit check programming
Medical Coding (MedDRA and WHO-DD)
Data cleaning and reconciliation
Database exports in Excel and SAS formats
Provision of Data Management Plan (DMP) and Edit Check Specifications
The Australian Government R&D grant means up to 43.5% rebate on clinical trial spend
No IND required for clinical trials
Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks
Globally accepted data
Data Management

Learn more about how we work

Request a Proposal or Talk to our Team  CONTACT US

More benefits

Avance Clinical can leverage all the benefits of Australia and New Zealand’s clinical ecosystem to deliver your study

Almost half clinical costs

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Rapid Start-up

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

Start-up time

Site Initiation Visit (SIV) and Study Start can be achieved in 5 – 6 weeks

No IND

No IND required for clinical trials

GMP material

Full GMP material is not mandated for Phase I clinical trials

Gene-therapy accreditation

Avance Clinical is an accredited gene-therapy CRO

Seasonal studies

Northern hemisphere Sponsors can conduct their studies year-round by taking advantage of Australia and New Zealand's counter-flu and allergy seasons

FDA and global regulatory data compliance

Major hospitals with world-class infrastructures and dedicated Clinical Trial Units with a long track record in FDA compliant research

Rebate

The Government R&D grant means up to 43.5% rebate on clinical trial spend

Start-up time

Site Initiation Visit (SIV) and Study Start achieved in 5 – 6 weeks

Capabilities

Full service CRO in Australia and New Zealand

195
Studies in the past 5 years
150
Experienced Team Members
10,000
Study participants (past 5 years)
24
Years of of CRO experience

“Avance Clinical’s clients are international biotech companies primarily from the United States, United Kingdom, Japan, China, South Korea, Taiwan, France, and Germany. These clients are seeking a premium CRO with the same experience and advanced technology platforms offered by the major global CROs, but with an agile and customer focused approach to clinical management in Australia and New Zealand.”

Supriya Lala KunduBest Practices Research Analyst, Frost & Sullivan

Ready To Partner with Us?

Contact Us